Literature DB >> 27449609

miR-613 inhibits proliferation and invasion of breast cancer cell via VEGFA.

Junzhao Wu1, Peng Yuan1, Qixin Mao1, Peng Lu2, Tian Xie1, Hanzhao Yang1, Chengzheng Wang1.   

Abstract

MicroRNAs (miRNAs) play important roles in the pathogenesis of many types of cancers by negatively regulating gene expression at posttranscriptional level. However, the role of microRNAs in breast cancer, has remained elusive. Here, we identified that miR-613 inhibits breast cancer cell proliferation by negatively regulates its target gene VEGFA. In breast cancer cell lines, CCK-8 proliferation assay indicated that the cell proliferation was inhibited by miR-613, while miR-613 inhibitor significantly promoted the cell proliferation. Transwell assay showed that miR-613 mimics significantly inhibited the migration and invasion of breast cancer cells, whereas miR-613 inhibitors significantly increased cell migration and invasion. Luciferase assays confirmed that miR-613 directly bound to the 3' untranslated region of VEGFA, and western blotting showed that miR-613 suppressed the expression of VEGFA at the protein levels. This study indicated that miR-613 negatively regulates VEGFA and inhibits proliferation and invasion of breast cancer cell lines. Thus, miR-613 may represent a potential therapeutic molecule for breast cancer intervention.
Copyright © 2016. Published by Elsevier Inc.

Entities:  

Keywords:  Breast cancer; VEGFA; miR-613

Mesh:

Substances:

Year:  2016        PMID: 27449609     DOI: 10.1016/j.bbrc.2016.07.031

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

1.  MicroRNA-613 suppresses proliferation, migration and invasion of osteosarcoma by targeting c-MET.

Authors:  Xinyu Li; Xufang Sun; Jing Wu; Zhihong Li
Journal:  Am J Cancer Res       Date:  2016-12-01       Impact factor: 6.166

2.  miR-206 inhibits liver cancer stem cell expansion by regulating EGFR expression.

Authors:  Caifeng Liu; Jun Li; Wei Wang; Xingyang Zhong; Feng Xu; Junhua Lu
Journal:  Cell Cycle       Date:  2020-04-14       Impact factor: 4.534

3.  LncRNA HOTAIR acts a competing endogenous RNA to control the expression of notch3 via sponging miR-613 in pancreatic cancer.

Authors:  Huihua Cai; Jie Yao; Yong An; Xuemin Chen; Weibo Chen; Di Wu; Boyang Luo; Yong Yang; Yong Jiang; Donglin Sun; Xiaozhou He
Journal:  Oncotarget       Date:  2017-05-16

4.  FAM225A facilitates colorectal cancer progression by sponging miR-613 to regulate NOTCH3.

Authors:  Xuexiu Zhang; Haoling Shi; Jianning Yao; Yanle Li; Bing Gao; Yanzhen Zhang; Chunfeng Wang; Haining Zhou; Lianfeng Zhang
Journal:  Cancer Med       Date:  2020-04-28       Impact factor: 4.452

5.  microRNA-613 exerts anti-angiogenic effect on nasopharyngeal carcinoma cells through inactivating the AKT signaling pathway by down-regulating FN1.

Authors:  Ru Gao; Qiaolei Feng; Guolin Tan
Journal:  Biosci Rep       Date:  2019-07-10       Impact factor: 3.840

6.  Long Non-Coding RNA UCA1 Modulates Paclitaxel Resistance in Breast Cancer via miR-613/CDK12 Axis.

Authors:  Chunhong Liu; Feng Jiang; Xueqin Zhang; Xiulong Xu
Journal:  Cancer Manag Res       Date:  2020-04-23       Impact factor: 3.989

7.  miR-552 promotes ovarian cancer progression by regulating PTEN pathway.

Authors:  Wenman Zhao; Tao Han; Bao Li; Qianyun Ma; Pinghua Yang; Hengyu Li
Journal:  J Ovarian Res       Date:  2019-12-09       Impact factor: 4.234

8.  Clinical significance and prospective molecular mechanism of MALAT1 in pancreatic cancer exploration: a comprehensive study based on the GeneChip, GEO, Oncomine, and TCGA databases.

Authors:  Zu-Cheng Xie; Yi-Wu Dang; Dan-Ming Wei; Peng Chen; Rui-Xue Tang; Qian Huang; Jiang-Hua Liu; Dian-Zhong Luo
Journal:  Onco Targets Ther       Date:  2017-08-10       Impact factor: 4.147

9.  Role of miR-613 as a tumor suppressor in glioma cells by targeting SOX9.

Authors:  Qiuling Sang; Xuejuan Liu; Daju Sun
Journal:  Onco Targets Ther       Date:  2018-04-30       Impact factor: 4.147

10.  Knockdown of circRAD18 Mitigates Breast Cancer Progression through the Regulation of miR-613/HK2 Axis.

Authors:  Hongliang Zang; Yuhui Li; Xue Zhang; Guomin Huang
Journal:  Cancer Manag Res       Date:  2020-05-19       Impact factor: 3.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.